Side-by-side comparison of AI visibility scores, market position, and capabilities
New York global insurance (NYSE: MET) at $70.986B 2024 revenue; PineBridge $1.2B acquisition ($100B AUM, Dec 2024) and Mesirow ($6B) expanding MetLife Investment Management under "New Frontier" strategy competing with Prudential.
MetLife, Inc. is a New York City, New York-based global insurance and financial services company — publicly traded on the New York Stock Exchange (NYSE: MET) as an S&P 500 component — providing life insurance, dental and vision insurance, retirement solutions, group benefits, and asset management through approximately 45,000 employees serving approximately 90 million customers in over 60 countries. In fiscal year 2024, MetLife reported $70.986 billion in total revenue. Founded in 1868 as the Metropolitan Life Insurance Company to serve Civil War-era disabled sailors and soldiers, MetLife converted from a mutual company to a publicly traded corporation in 2000 (ending 85 years as a mutual). CEO Michel A. Khalaf (since 2019) launched the "New Frontier" strategy in 2024, focused on accelerating growth through digital transformation, enhanced customer experiences, and strategic acquisitions in asset management. MetLife's asset management arm, MetLife Investment Management (MIM), announced the $1.2 billion acquisition of PineBridge Investments from Pacific Century Group in December 2024 — adding approximately $100 billion in AUM to MIM's platform ($800M at close, $200M tied to 2025 financial metrics, $200M multi-year earnout). In January 2025, MetLife acquired investment teams from Mesirow managing $6 billion in assets. MetLife operates through six segments: Group Benefits (employer-sponsored life, dental, vision, disability), Retirement and Income Solutions (RIS, pension risk transfer, structured settlements), Asia, Latin America, EMEA, and MetLife Holdings (run-off blocks).
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.